Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6800
+0.0500 (3.07%)
NASDAQ · Last Trade: Mar 29th, 6:53 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors